Jump To Top

groundrushairsports

drugs

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIOVAN® Valsartan Consumer Medicine Information What is in this leaflet This leaflet answers some...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PERINDO® COMBI 4/1.25 perindopril (pronounced per-in-do-pril) and indapamide (pronounced in-dap-a-mide) Consumer...

As reported in Nature Communications, researchers from Cleveland Clinic’s Lerner Research Institute have developed a novel, patient-derived model of ulcerative colitis, which will help advance studies...

Highly promising vaccines have recently emerged for COVID-19, but this doesn’t mean research into other treatments can slow down. There is still no cure for the disease, and people will likely continue...

A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows. The test, known as a liquid biopsy,...

The prescription of potentially inappropriate medications to older adults is linked to increased hospitalizations, and it costs patients, on average, more than $450 per year, according to a new University...

More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information...

Glutamate is the messenger substance the brain uses to pass on excitatory signals. Receptors for this neurotransmitter are a promising target for drug development, as they are involved in many pathological...

Scientists identify 21 drugs that show promise for treating COVID-19 – including four that might be used with remdesivir to combat the virus Researchers at Sanford Burnham Prebys Medical Discovery...

(HealthDay)—In 2018, opioid overdose deaths declined, but deaths involving alcohol, suicide, synthetic opioids, and other psychostimulants rose, according to a brief released May 21 by the Trust for...